All treatments
Treatment
Glepaglutide 20.0 mg/mL clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A 104-WEEK, MULTICENTER, SINGLE-ARM, LONG-TERM, PHASE 3 EXTENSION TRIAL INVESTIGATING THE SAFETY AND EFFICACY OF GLEPAGLUTIDE IN ADULT PATIENTS WITH SHORT BOWEL SYNDROME (SBS) COMPLETING THE EASE SBS 2 TRIAL
This study looks at a new medicine called glepaglutide for adults with short bowel syndrome. It checks how safe and effective it is over a long time, especially what side effects people might have and if it helps reduce their need for IV feeding.
For: Short bowel syndromeDenmark · Belgium · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A DOUBLE-BLIND PHASE 3 EXTENSION TRIAL ASSESSING THE LONG TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME (SBS)
This study is looking at a new medicine called glepaglutide for people with Short Bowel Syndrome. It wants to see how safe and effective it is over a long time. Researchers will compare glepaglutide to a dummy medicine to see if it helps reduce the need for intravenous feeding.
For: Short Bowel SyndromeFrance · Belgium · Germany